Bed Bath & Beyond Beats Q1 Estimates with First Revenue Growth in 19 Quarters
Bed Bath & Beyond beat forecasts, cut costs, improved sales, and is shifting from survival to growth with a leaner business model.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Bed Bath & Beyond beat forecasts, cut costs, improved sales, and is shifting from survival to growth with a leaner business model.
Starboard buys big stake in Flowserve, pushes for higher profits as AI boosts power demand; stock rises on growth hopes.
Snap upgraded to Buy with 77% upside; analysts expect first profit, rising subscriptions, and stronger growth ahead.
Critical Metals to buy European Lithium for $835M, gaining full control of a major rare earth project and boosting cash.
POET stock fell after Marvell canceled orders over confidentiality issues, but the company still sees growth in AI tech.
Microsoft and OpenAI updated deal: OpenAI gets more freedom, Azure remains main partner, revenue rules simplified, AGI clause removed.